VLA 0.00% $1.75 viralytics limited

Keytruda and Merck article about problems with lung cancer trial., page-3

  1. 12,404 Posts.
    lightbulb Created with Sketch. 1110
    Hi,
    I think there is a real chance Merck partner with Cavatak in this indication.
    http://www.fiercepharma.com/pharma/...ts-after-awkward-eu-keytruda-combo-withdrawal
    Aloha.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.